Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Return on Sales (2016 - 2025)

Aytu Biopharma (AYTU) has disclosed Return on Sales for 14 consecutive years, with 0.0% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Sales fell 1.0% to 0.0% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.0%, a 2.0% increase, with the full-year FY2025 number at 0.01%, up 6.0% from a year prior.
  • Return on Sales was 0.0% for Q4 2025 at Aytu Biopharma, down from 0.0% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.02% in Q3 2024 to a low of 2.19% in Q1 2022.
  • A 5-year average of 0.33% and a median of 0.06% in 2023 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: plummeted -169bps in 2022, then skyrocketed 188bps in 2023.
  • Aytu Biopharma's Return on Sales stood at 0.5% in 2021, then soared by 49bps to 0.25% in 2022, then skyrocketed by 82bps to 0.04% in 2023, then surged by 117bps to 0.01% in 2024, then plummeted by -76bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Return on Sales are 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).